Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Cresco Labs Inc. (C:CL)

Business Focus: Pharmaceuticals (NEC)

INK Edge Outlook

Mostly sunny as of June 01, 2024
For the latest outlook, get the company report

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for CL within the last 6 months
Loading...
See all filings within the past 6 months

Company News

May 15, 2024 07:30 ET
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended March 31, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website,
Read full article
May 09, 2024 07:30 ET
Cresco Labs Announces May Conference Participation
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced planned participation in upcoming conferences in May 2024.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.99
--
--
Price to Sales - TTM
0.69
3.46
3.80
Price to Book - most recent quarter
1.40
3.67
2.40
Price to Cash Flow per share - TTM
--
8.26
9.54
Price to Free Cash Flow per share - TTM
12.15
12.07
14.89
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
May 31, 202483,464-925
May 15, 202484,389-97,782
Apr 30, 2024182,17164,236
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs' national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy's. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy's offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products.

See business summary

 

Twitter

Search (past week) for $CL.CA

  • No tweets found